Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone for Sudden Sensorineural Hearing Loss
IRCT20211010052721N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Oct 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexamethasone in acute sensorineural hearing loss, sponsored by Mashhad University of Medical Sciences. Started Oct 2021; status: completed.
02
Drugs
dexamethasone
03
Conditions
acute sensorineural hearing loss
Beyond the preview
Go deeper on IRCT20211010052721N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211010052721N1.